Thyrocare Technologies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 204.51 | 182.85 | 178.41 |
| Operating Expense | 133.32 | 122.37 | 118.23 |
| Net Profit | 43.03 | 36.05 | 21.95 |
| Net Profit Margin | 21.04 | 19.72 | 12.30 |
| Earning Per Share | 8.12 | 6.80 | 4.08 |
| EBIDTA | 70.32 | 59.92 | 48.76 |
| Effective Tax Rate | 23.87 | 23.64 | 23.98 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 204.51 |
| Operating Expense | 133.32 |
| Net Profit | 43.03 |
| Net Profit Margin | 21.04 |
| Earning Per Share | 8.12 |
| EBIDTA | 70.32 |
| Effective Tax Rate | 23.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 633.10 | 524.02 | 486.46 |
| Operating Expenses Annual | 446.08 | 390.14 | 374.45 |
| Operating Profit Annual | 200.36 | 141.06 | 117.40 |
| Interest Annual | 2.63 | 3.73 | 2.25 |
| Depreciation | 37.72 | 31.55 | 26.56 |
| Net Profit Annual | 95.78 | 71.14 | 56.97 |
| Tax Annual | 55.43 | 27.08 | 24.10 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 633.10 |
| Operating Expenses Annual | 446.08 |
| Operating Profit Annual | 200.36 |
| Interest Annual | 2.63 |
| Depreciation | 37.72 |
| Net Profit Annual | 95.78 |
| Tax Annual | 55.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.56 | 12.37 | 11.50 |
| Cash Flow from Operations | 190.76 | 155.19 | 120.02 |
| Cash Flow from Investing | -54.70 | -80.29 | -31.65 |
| Cash Flow from Financing | -124.44 | -83.71 | -87.50 |
| Cash Flow at the End | 15.18 | 3.56 | 12.37 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 3.56 |
| Cash Flow from Operations | 190.76 |
| Cash Flow from Investing | -54.70 |
| Cash Flow from Financing | -124.44 |
| Cash Flow at the End | 15.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 31.73 | 27.14 | 24.60 |
| PBIT Margin (%) | 24.38 | 19.67 | 17.60 |
| PBT Margin (%) | 16.62 | 15.64 | 13.72 |
| Net PROFIT Margin (%) | 15.13 | 13.58 | 11.71 |
| Return On Networth / Equity (%) | 18.23 | 13.75 | 10.94 |
| Return On Networth /Employed (%) | 27.26 | 18.63 | 15.73 |
| Return On Assets (%) | 16.94 | 12.90 | 10.42 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.04 |
| Asset Turnover Ratio (%) | 1.12 | 0.95 | 0.89 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 31.73 |
| PBIT Margin (%) | 24.38 |
| PBT Margin (%) | 16.62 |
| Net PROFIT Margin (%) | 15.13 |
| Return On Networth / Equity (%) | 18.23 |
| Return On Networth /Employed (%) | 27.26 |
| Return On Assets (%) | 16.94 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 1.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 156.59 | 158.29 | 155.63 |
| Total Current Assets Annual | 298.56 | 245.65 | 235.37 |
| Non Current Assets Annual | 377.79 | 374.62 | 376.50 |
| Total Shareholders Funds Annual | 537.10 | 513.81 | 521.04 |
| Total Assets Annual | 676.35 | 620.27 | 611.87 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 156.59 |
| Total Current Assets Annual | 298.56 |
| Non Current Assets Annual | 377.79 |
| Total Shareholders Funds Annual | 537.10 |
| Total Assets Annual | 676.35 |
EPS (INR)
Expected
9.06
Reported
9.05
Surprise
-0.11%
Jun 2025
EPS beaten by -0.11%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 1.71%
